Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Beyond the Prognosis and Treatment: Cancer Survivorship

    Cancer survivors have a diverse range of experiences with their diagnoses, treatment, and life after cancer.

    June 2, 2022| Max Mallet
  • Clinical Trials Drive Immunotherapy Progress. Are They for You?

    Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments. 

    May 19, 2022| Max Mallet
  • Skin Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Skin Cancer Awareness month, discover new research, treatments, and progress for a future immune to skin…

    May 10, 2022| CRI Staff
  • How a Day of Golf and Beer Raised Money for Cancer Immunotherapy Research

    Birdies & Brews mixes beer and golf while raising funds for cancer immunotherapy research.

    May 6, 2022| Max Mallet
  • Bladder Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Bladder Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 4, 2022| CRI Staff
  • Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates

    This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…

    May 3, 2022| CRI Staff
  • Melanoma Monday: 2022 Immunotherapy Research Updates

    This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.

    May 2, 2022| CRI Staff
  • The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD

    CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…

    April 18, 2022| Arthur N. Brodsky, PhD
  • AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells

    At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…

    April 14, 2022| Arthur N. Brodsky, PhD
Previous Page
1 … 24 25 26 27 28 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal